<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30550976</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN><JournalIssue CitedMedium="Internet"><Volume>528</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>Cell-type specificity and functional redundancy of RIG-I-like receptors in innate immune sensing of Coxsackievirus B3 and encephalomyocarditis virus.</ArticleTitle><Pagination><StartPage>7</StartPage><EndPage>18</EndPage><MedlinePgn>7-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2018.12.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0042-6822(18)30367-2</ELocationID><Abstract><AbstractText>The contributions of RIG-I and MDA5 receptors to sensing viruses of the Picornaviridae family were investigated. The picornaviruses encephalomyocarditis virus (EMCV) and Coxsackievirus B3 (CVB3) are detected by both MDA5 and RIG-I in bone marrow derived macrophages. In macrophages from wild type mice, type I IFN is produced early after infection; IFN&#x3b2; synthesis is reduced in the absence of each sensor, while IFN&#x3b1; production is reduced in the absence of MDA5. EMCV and CVB3 do not replicate in murine macrophages, and their detection is different in murine embryonic fibroblasts (MEFs), in which the viruses replicate to high titers. In MEFs RIG-I was essential for the expression of type I IFNs but contributes to increased yields of CVB3, while MDA5 inhibited CVB3 replication but in an IFN independent manner. These observations demonstrate functional redundancy within the innate immune response to picornaviruses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Francisco</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Vagelos College of Physicians &amp; Surgeons of Columbia University, 701 W. 168th St., New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suthar</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gale</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Amy B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Vagelos College of Physicians &amp; Surgeons of Columbia University, 701 W. 168th St., New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Racaniello</LastName><ForeName>Vincent R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Vagelos College of Physicians &amp; Surgeons of Columbia University, 701 W. 168th St., New York, NY 10032, USA. Electronic address: vrr1@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AI083019</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI139775</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI118916</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI050754</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI127463</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C503356">Ddx58 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C510592">Ifih1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004686" MajorTopicYN="N">Encephalomyocarditis virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057507" MajorTopicYN="N">Mice, 129 Strain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Innate immunity</Keyword><Keyword MajorTopicYN="N">Interferon</Keyword><Keyword MajorTopicYN="N">MDA5</Keyword><Keyword MajorTopicYN="N">Macrophage</Keyword><Keyword MajorTopicYN="N">Picornavirus</Keyword><Keyword MajorTopicYN="N">RIG-I</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30550976</ArticleId><ArticleId IdType="mid">NIHMS1516776</ArticleId><ArticleId IdType="pmc">PMC6401217</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2018.12.003</ArticleId><ArticleId IdType="pii">S0042-6822(18)30367-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laitinen OH, Honkanen H, Pakkanen O, Oikarinen S, Hankaniemi MM, Huhtala H, Ruokoranta T, Lecouturier V, Andre P, Harju R, Virtanen SM, Lehtonen J, Almond JW, Simell T, Simell O, Ilonen J, Veijola R, Knip M, Hyoty H. 2014. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63:446&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">23974921</ArticleId></ArticleIdList></Reference><Reference><Citation>Canelli E, Luppi A, Lavazza A, Lelli D, Sozzi E, Martin AM, Gelmetti D, Pascotto E, Sandri C, Magnone W, Cordioli P. 2010. Encephalomyocarditis virus infection in an Italian zoo. Virology journal 7:64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848215</ArticleId><ArticleId IdType="pubmed">20298561</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S 2009. Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol Rev 227:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19120470</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103:8459&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19076341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H, Kawai T, Akira S. 2009. Pathogen recognition in the innate immune response. The Biochemical journal 420:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19382893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5&#x2019;-phosphates. Science 314:997&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">17038589</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev 227:75&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins C, Gale M Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 22:41&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3172156</ArticleId><ArticleId IdType="pubmed">20061127</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M Jr., Patel SS, Marcotrigiano J. 2011. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479:423&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430514</ArticleId><ArticleId IdType="pubmed">21947008</ArticleId></ArticleIdList></Reference><Reference><Citation>Komuro A, Bamming D, Horvath CM. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43:350&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575845</ArticleId><ArticleId IdType="pubmed">18703349</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahasi K, Kumeta H, Tsuduki N, Narita R, Shigemoto T, Hirai R, Yoneyama M, Horiuchi M, Ogura K, Fujita T, Inagaki F. 2009. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J Biol Chem 284:17465&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719387</ArticleId><ArticleId IdType="pubmed">19380577</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104:582&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1766428</ArticleId><ArticleId IdType="pubmed">17190814</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M Jr., Inagaki F, Fujita T. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29:428&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">18242112</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell Microbiol 8:907&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16681834</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153868</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR. 2007. MDA5 is cleaved in poliovirus-infected cells. J Virol 81:3677&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, van Kuppeveld FJ. 2014. Induction and suppression of innate antiviral responses by picornaviruses. Cytokine Growth Factor Rev 25:577&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172595</ArticleId><ArticleId IdType="pubmed">25086453</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, Gilfillan S, Diamond MS, Unanue ER, Colonna M. 2011. RNA sensor-induced type I IFN prevents diabetes caused by a beta cell-tropic virus in mice. J Clin Invest 121:1497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069767</ArticleId><ArticleId IdType="pubmed">21403398</ArticleId></ArticleIdList></Reference><Reference><Citation>Huhn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodstrom-Tullberg M. 2010. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection. Virology 401:42&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20206372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn H, Palmenberg AC. 1995. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J Virol 69:2697&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188958</ArticleId><ArticleId IdType="pubmed">7884926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Tu Z, Chapman N, Hufnagel G. 1995. Genetics of coxsackievirus B3 cardiovirulence. Eur Heart J 16 Suppl O:15&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaheri A, Pagano JS. 1965. Infectious poliovirus RNA: a sensitive method of assay. Virology 27:435&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">4285107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JM, Racaniello VR. 2009. Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol 83:4412&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto M, Komuro A. 2017. PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2. Biochem Biophys Res Commun 494:227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">29032202</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S 2009. Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunological reviews 227:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19120470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A, Reis e Sousa C. 2007. Innate recognition of viruses. Immunity 27:370&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">17892846</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M Jr. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80:9424&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1617238</ArticleId><ArticleId IdType="pubmed">16973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Errett JS, Suthar MS, McMillan A, Diamond MS, Gale M Jr. 2013. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol 87:11416&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807316</ArticleId><ArticleId IdType="pubmed">23966395</ArticleId></ArticleIdList></Reference><Reference><Citation>Papon L, Oteiza A, Imaizumi T, Kato H, Brocchi E, Lawson TG, Akira S, Mechti N. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology doi:S0042&#x2013;6822(09)00489&#x2013;9 [pii] 10.1016/j.virol.2009.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.08.009</ArticleId><ArticleId IdType="pubmed">19733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambros V, Baltimore D. 1980. Purification and properties of a HeLa cell enzyme able to remove the 5&#x2019;-terminal protein from poliovirus RNA. J Biol Chem 255:6739&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">6248532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewlett MJ, Rose JK, Baltimore D. 1976. 5&#x2019;-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A 73:327&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC335900</ArticleId><ArticleId IdType="pubmed">174102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomoto A, Kitamura N, Golini F, Wimmer E. 1977. The 5&#x2019;-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A 74:5345&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC431713</ArticleId><ArticleId IdType="pubmed">202952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell AM, Gale M Jr. 2015. RIG-I in RNA virus recognition. Virology 479&#x2013;480:110&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424084</ArticleId><ArticleId IdType="pubmed">25749629</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, Stevanovic S, Klingel K. 2008. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82:8149&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519575</ArticleId><ArticleId IdType="pubmed">18550677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SF, Lloyd RE. 1991. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease. Virology 182:615&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">1850921</ArticleId></ArticleIdList></Reference><Reference><Citation>Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282:7576&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17204473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Nagarkar DR, Bowman ER, Schneider D, Gosangi B, Lei J, Zhao Y, McHenry CL, Burgens RV, Miller DJ, Sajjan U, Hershenson MB. 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 183:6989&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">18250457</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson SJ, Goh FG, Banks H, Krausgruber T, Kotenko SV, Foxwell BM, Udalova IA. 2009. The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A 106:11564&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710658</ArticleId><ArticleId IdType="pubmed">19570999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3670185</ArticleId><ArticleId IdType="pubmed">20451243</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76:5532&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137057</ArticleId><ArticleId IdType="pubmed">11991981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Dittmann M, Peisley A, Hoffmann HH, Gilmore RH, Schmidt T, Schmidt-Burgk J, Hornung V, Rice CM, Hur S. 2015. ATP-dependent effector-like functions of RIG-I-like receptors. Mol Cell 58:541&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4427555</ArticleId><ArticleId IdType="pubmed">25891073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>